TAK - Takeda Pharmaceutical Co - ADR
Close
14.89
-0.060 -0.403%
Share volume: 1,859,532
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$14.95
-0.06
-0.40%
Fundamental analysis
43%
Profitability
17%
Dept financing
28%
Liquidity
54%
Performance
70%
Performance
5 Days
-1.26%
1 Month
9.08%
3 Months
14.27%
6 Months
3.74%
1 Year
1.30%
2 Year
17.33%
Key data
Stock price
$14.89
DAY RANGE
$14.80 - $14.92
52 WEEK RANGE
$12.58 - $15.74
52 WEEK CHANGE
$0.01
DIVIDEND
$0.2922
EX-DIVIDEND DATE
03/27/2024
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Christophe Weber
Region: US
Website: https://www.takeda.com/
Employees: 48,000
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.takeda.com/
Employees: 48,000
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
Recent news